GPP
DVAX

Great Point Partners’s Dynavax Technologies DVAX Stock Holding History

Great Point Partners’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-595,879
Closed -$7.73M – 31
2025
Q1 		$7.73M Sell
595,879
-264,121
-31% -$3.49M 4.09% 10
2024
Q4 		$11M Sell
860,000
-466,234
-35% -$5.64M 5.18% 7
2024
Q3 		$14.8M Sell
1,326,234
-1,047,766
-44% -$11.5M 4.35% 8
2024
Q2 		$26.7M Buy
2,374,000
+1,109,080
+88% +$12.9M 5.11% 7
2024
Q1 		$15.7M Buy
+1,264,920
New +$16.5M 2.45% 20
2017
Q3 		– Sell
-435,500
Closed -$4.2M – 39
2017
Q2 		$4.2M Buy
+435,500
New +$2.83M 0.75% 28

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Great Point Partners's DVAX Position: Q2 2025 in Review

Great Point Partners sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 595,879 shares — an estimated $7.73M sold.

Great Point Partners first reported a position in DVAX in Q2 2017 and held it in 6 quarters. The position peaked at $26.7M in Q2 2024. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Great Point Partners reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Great Point Partners sold 595,879 Dynavax Technologies shares in Q2 2025, an estimated $7.73M.
  • Great Point Partners first reported a position in Dynavax Technologies in Q2 2017 and held it in 6 quarters.
  • Great Point Partners's Dynavax Technologies position peaked at $26.7M in Q2 2024.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Great Point Partners's 13F filing for Q2 2025, filed 14 Aug 2025.